Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-134-1 | CAS number: 164651-56-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In vitro bacterial reverse mutation assay
Non Mutagenic
in vitro gene mutation study in mammalian cells
Non mutagenic
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Non clastogenic
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
The assessment of mutagenicity potential of the substance is based on one in vitro studies, carried out on Similar Substance 01, and one in vivo study, carried aout on Similar Substance 02.
Further information are reported in the Read Across justification attached to section 13.
IN VITRO BACTERIAL REVERSE MUTATION TEST
An ames test is in progress and expected negative.
IN VITRO MAMMALIAN CELL GENE MUTATION TEST
The substance was tested on chinese hamster cells V79 according to OECD 476. Test article was a greenblack powder with purity of 54.62%. The test substance was dissolved in DMSO. The cells were treated in the experiments with metabolic activation for 5 hours and in the experiments without metabolic activation for 21 hours.
A preliminary range finding test was run assessing cytotoxicity. The substance was tested at concentrations up to 500.0 µg/ml. Higher concentration could not be applied due to solubility limitations in the vehicle. In the part with metabolic activation, at the highest concentration a 100 % growth inhibiting effect could be seen, while the next lower concentration of 250.0 µg/ml inhibited 90.92 %. Without metabolic activation treatment with substance proved growth inhibiting down to the concentration of 125 µg/ml. The next lower concentration of 62.5 µg/ml revealed an acute inhibition of growth of 63.99 %. Accordingly, 250.0 µg/ml with and 100.0 µg/ml without metabolic activation were chosen as highest concentrations for the first mutagenicity assay.
Mutagenicity test with metabolic activation: the original experiment was performed at the following concentrations: 9.26, 27.78, 83.33 and 250.0 µg/ml. The mean growth inhibiting value found at the highest concentration after treatment was 71.35 %. No toxicity was seen after expression.
In the confirmatory experiment the concentrations applied were 11.11, 33.33, 100.0 and 300.0 µg/ml. The highest concentration revealed a mean acute growth inhibition of 93.76%. The mean growth inhibitory effect after the expression period was 12.28 %.
Mutagenicity test without metabolic activation: the original experiment was performed at the following concentrations: 3.70, 11.11, 33.33 and 100.0 µg/ml. The mean growth inhibition value found at the highest concentration after treatment was 38.33 %. No toxicity was seen after expression.
In the confirmatory experiment the concentrations applied were 5.56, 16.67, 50.0 and 150.0 µg/ml. The highest concentration revealed a mean acute growth inhibitory effect of 71.47 %. No toxicity was seen after expression.
For both experiments comparison of the number of mutant colonies in the controls and in the cultures treated with the various concentrations of the test substance revealed no relevant increase of the mutant frequencies as determined by the screening with 6-TG.
Based on the results of two independently performed experiments and under the given experimental conditions, it is concluded that the substance and its metabolites did not show any mutagenic activity in this forward mutation system.
IN VIVO MAMMALIAN SOMATIC CELL STUDY: CYTOGENICITY/ERYTHROCYTE MICRONUCLEUS
The study was conducted to investigate the potential of the test substance to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the rat according to OECD Guideline 474, EPA OPPTS 870.5395 and EU Method B.12, in compliance with GLP.
The test compound was dissolved in deionized water and was given twice at an interval of 24 hours as oral doses of 2000 mg per kg body weight to male and female rats (Hsd:Sprague Dawley). At study start the animals were 6 weeks of age and had mean body weights of 181.4 g (M) and 146.5 g (F). According to the test procedure the animals were killed 24 hours after the last administration.
Endoxan® was used as positive control substance and was administered once orally at a dose of 40 mg per kg body weight.
The number of polychromatic erythrocytes containing micronuclei was not significantly increased compared with the control. The ratio of polychromatic erythrocytes to total erythrocytes in both male and female animals remained unaffected by the treatment with the test substance and differed less than 20 % from the control value.
Endoxan®induced a marked statistically significant increase in the number of polychromatic cells with micronuclei, indicating the sensitivity of the test system. The ratio of polychromatic erythrocytes to total erythrocytes was not changed to a significant extent.
Under the conditions of the present study the results indicate that the test substance is not clastogenic in the micronucleus test in vivo.
Justification for classification or non-classification
GERM CELL MUTAGENICITY
This hazard class is primarily concerned with substances that may cause mutations in the germ cells of humans that can be transmitted to the progeny. However, the results from mutagenicity or genotoxicity tests in vitro and in mammalian somatic and germ cells in vivo are also considered in classifying substances and mixtures within this hazard class.
Category 1: Substances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans. Substances known to induce heritable mutations in the germ cells of humans.
Categoty 2: Substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans.
The classification in Category 2 is based on:
— positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:
— somatic cell mutagenicity tests in vivo, in mammals; or
— other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.
Note: Substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, shall be considered for classification as Category 2 mutagens.
Classification for heritable effects in human germ cells is made on the basis of well conducted, sufficiently validated tests as:
- In vivo somatic cell mutagenicicty tests such as these indicated in paragraph 3.5.2.3.5:
— mammalian bone marrow chromosome aberration test;
— mouse spot test;
— mammalian erythrocyte micronucleus test.
- In vitro mutagenicity tests such as these indicated in 3.5.2.3.8:
— in vitro mammalian chromosome aberration test;
— in vitro mammalian cell gene mutation test;
— bacterial reverse mutation tests.
An in vitro mammalian cell gene mutation test is available and the test substance does not show any mutagenic effect.
As per REACH Regulation requirements, a further in vivo study is considered in which the test substance didn’t induce increase the number of polychromatic cells with micronuclei.
Therefore, as reported in the Flow chart R.7.7 -1, no further test are required and it is possible to conclude that the test substance is Not Classified for Mutagenic Toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.